ABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Funnel Chest/complications , Funnel Chest/diagnosis , Funnel Chest/surgery , Anesthesia, General/methods , Hemangioendothelioma/complications , Hemangioendothelioma/diagnosis , Hemangioendothelioma/surgery , Lidocaine/pharmacology , Lidocaine/therapeutic useABSTRACT
No disponible
Subject(s)
Humans , Male , Adolescent , Purpura/diagnosis , Exanthema/diagnosis , Embolism, Fat/diagnosis , Diagnosis, DifferentialSubject(s)
Embolism, Fat/complications , Fractures, Bone/complications , Purpura/etiology , Adolescent , Fatal Outcome , Humans , Male , Pulmonary Gas Exchange , SyndromeABSTRACT
AIMS: To compare the efficacy and feasibility of the sciatic nerve block performed using either a posterior or a lateral approach to the popliteal fossa, taking into consideration patient comfort during puncture and postoperative analgesia. PATIENTS AND METHODS: Sixty patients scheduled for foot surgery were randomly assigned to 2 groups: a posterior approach was used in performing the sciatic nerve block in 1 group (n = 30) and a lateral approach was in the other group (n = 30). The local anesthetic employed was mepivacaine 1%. RESULTS: Duration of sensory block was used significantly longer with the lateral approach (5.4 hours, range 3.3-8 hours) than with the posterior approach (4.4 hours, range 1.5-7 hours) (P < 0.001). Time to onset of the block was significantly shorter with the lateral approach (10 minutes, range 5-25 minutes) than with the posterior approach (17 minutes, range 4-45 minutes) (P < 0.01). Quality of the blockade was similar with both approaches. CONCLUSIONS: The lateral approach to the block of the sciatic nerve in the popliteal fossa provides analgesia comparable to that obtained with the posterior approach, with a faster onset and longer postoperative duration.
Subject(s)
Anesthetics, Local/administration & dosage , Mepivacaine/administration & dosage , Nerve Block/methods , Sciatic Nerve , Adult , Aged , Aged, 80 and over , Feasibility Studies , Female , Foot/surgery , Humans , Leg , Male , Middle AgedABSTRACT
We review the use of urapidil to manage hypertension in two patients undergoing adrenalectomy for pheochromocytoma and aldosterone producing adenoma. Bolus administration (25 mg/i.v.) of urapidil provided good control of blood pressure during surgical manipulation of the tumor, although continuous perfusion of the drug was required by one patient before complete excision was achieved. No changes in heart rate or sudden decrease in blood pressure were observed. We believe that urapidil may be useful for treating hypertension during tumor adrenalectomy.
